Open Access
Open access
International Journal of Bioprinting, volume 6, issue 4, pages 1-20

Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19)

Kosheleva Nastasia
Zurina Irina
Vosough Massoud
Zahmatkesh Ensieh
Khoshdel Rad Niloofar
Peshkova Maria
Lipina Marina
Publication typeJournal Article
Publication date2020-01-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor8.4
ISSN24248002, 24247723
Biotechnology
Materials Science (miscellaneous)
Industrial and Manufacturing Engineering
Abstract
While the number of studies related to severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is constantly growing, it is essential to provide a framework of modeling viral infections. Therefore, this review aims to describe the background presented by earlier used models for viral studies and an approach to design an “ideal” tissue model for SARS-CoV-2 infection. Due to the previous successful achievements in antiviral research and tissue engineering, combining the emerging techniques such as bioprinting, microfluidics, and organoid formation are considered to be one of the best approaches to form in vitro tissue models. The fabrication of an integrated multi-tissue bioprinted platform tailored for SARS-CoV-2 infection can be a great breakthrough that can help defeat coronavirus disease in 2019.

Citations by journals

1
2
Emergent Materials
Emergent Materials, 2, 6.67%
Emergent Materials
2 publications, 6.67%
Journal of Manufacturing Systems
Journal of Manufacturing Systems, 2, 6.67%
Journal of Manufacturing Systems
2 publications, 6.67%
Drug Discovery Today
Drug Discovery Today, 1, 3.33%
Drug Discovery Today
1 publication, 3.33%
Bio-Design and Manufacturing
Bio-Design and Manufacturing, 1, 3.33%
Bio-Design and Manufacturing
1 publication, 3.33%
Cells
Cells, 1, 3.33%
Cells
1 publication, 3.33%
Developmental Biology
Developmental Biology, 1, 3.33%
Developmental Biology
1 publication, 3.33%
Vasa - European Journal of Vascular Medicine
Vasa - European Journal of Vascular Medicine, 1, 3.33%
Vasa - European Journal of Vascular Medicine
1 publication, 3.33%
Biomedical Microdevices
Biomedical Microdevices, 1, 3.33%
Biomedical Microdevices
1 publication, 3.33%
Micromachines
Micromachines, 1, 3.33%
Micromachines
1 publication, 3.33%
Pharmaceuticals
Pharmaceuticals, 1, 3.33%
Pharmaceuticals
1 publication, 3.33%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 1, 3.33%
Frontiers in Bioengineering and Biotechnology
1 publication, 3.33%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 1, 3.33%
Frontiers in Cell and Developmental Biology
1 publication, 3.33%
Frontiers in Immunology
Frontiers in Immunology, 1, 3.33%
Frontiers in Immunology
1 publication, 3.33%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 1, 3.33%
Frontiers in Cellular and Infection Microbiology
1 publication, 3.33%
Cell and Tissue Research
Cell and Tissue Research, 1, 3.33%
Cell and Tissue Research
1 publication, 3.33%
Biomedical Materials (Bristol)
Biomedical Materials (Bristol), 1, 3.33%
Biomedical Materials (Bristol)
1 publication, 3.33%
Advanced Drug Delivery Reviews
Advanced Drug Delivery Reviews, 1, 3.33%
Advanced Drug Delivery Reviews
1 publication, 3.33%
Research in Veterinary Science
Research in Veterinary Science, 1, 3.33%
Research in Veterinary Science
1 publication, 3.33%
Additive Manufacturing Letters
Additive Manufacturing Letters, 1, 3.33%
Additive Manufacturing Letters
1 publication, 3.33%
Bioprinting
Bioprinting, 1, 3.33%
Bioprinting
1 publication, 3.33%
International Journal of Energy Research
International Journal of Energy Research, 1, 3.33%
International Journal of Energy Research
1 publication, 3.33%
ACS Nano
ACS Nano, 1, 3.33%
ACS Nano
1 publication, 3.33%
IEEE Reviews in Biomedical Engineering
IEEE Reviews in Biomedical Engineering, 1, 3.33%
IEEE Reviews in Biomedical Engineering
1 publication, 3.33%
Drug Development and Industrial Pharmacy
Drug Development and Industrial Pharmacy, 1, 3.33%
Drug Development and Industrial Pharmacy
1 publication, 3.33%
Journal of Gene Medicine
Journal of Gene Medicine, 1, 3.33%
Journal of Gene Medicine
1 publication, 3.33%
1
2

Citations by publishers

1
2
3
4
5
6
7
8
Elsevier
Elsevier, 8, 26.67%
Elsevier
8 publications, 26.67%
Springer Nature
Springer Nature, 5, 16.67%
Springer Nature
5 publications, 16.67%
Frontiers Media S.A.
Frontiers Media S.A., 4, 13.33%
Frontiers Media S.A.
4 publications, 13.33%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 10%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 10%
Wiley
Wiley, 2, 6.67%
Wiley
2 publications, 6.67%
Hogrefe Publishing Group
Hogrefe Publishing Group, 1, 3.33%
Hogrefe Publishing Group
1 publication, 3.33%
IOP Publishing
IOP Publishing, 1, 3.33%
IOP Publishing
1 publication, 3.33%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 3.33%
American Chemical Society (ACS)
1 publication, 3.33%
IEEE
IEEE, 1, 3.33%
IEEE
1 publication, 3.33%
Taylor & Francis
Taylor & Francis, 1, 3.33%
Taylor & Francis
1 publication, 3.33%
1
2
3
4
5
6
7
8
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Shpichka A. et al. Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19) // International Journal of Bioprinting. 2020. Vol. 6. No. 4. pp. 1-20.
GOST all authors (up to 50) Copy
Shpichka A., Kosheleva N., Zurina I., Timashev P., Golubeva E., Bikmulina P., Peshkova M., Zahmatkesh E., Khoshdel Rad N., Lipina M., Vosough M. Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19) // International Journal of Bioprinting. 2020. Vol. 6. No. 4. pp. 1-20.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.18063/IJB.V6I4.302
UR - https://doi.org/10.18063%2FIJB.V6I4.302
TI - Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19)
T2 - International Journal of Bioprinting
AU - Shpichka, Anastasia
AU - Kosheleva, Nastasia
AU - Zurina, Irina
AU - Timashev, Peter
AU - Golubeva, Elena
AU - Bikmulina, Polina
AU - Peshkova, Maria
AU - Zahmatkesh, Ensieh
AU - Khoshdel Rad, Niloofar
AU - Lipina, Marina
AU - Vosough, Massoud
PY - 2020
DA - 2020/01/01 00:00:00
PB - Whioce Publishing Pte. Ltd
SP - 1-20
IS - 4
VL - 6
PMID - 33089000
SN - 2424-8002
SN - 2424-7723
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Shpichka,
author = {Anastasia Shpichka and Nastasia Kosheleva and Irina Zurina and Peter Timashev and Elena Golubeva and Polina Bikmulina and Maria Peshkova and Ensieh Zahmatkesh and Niloofar Khoshdel Rad and Marina Lipina and Massoud Vosough},
title = {Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19)},
journal = {International Journal of Bioprinting},
year = {2020},
volume = {6},
publisher = {Whioce Publishing Pte. Ltd},
month = {jan},
url = {https://doi.org/10.18063%2FIJB.V6I4.302},
number = {4},
pages = {1--20},
doi = {10.18063/IJB.V6I4.302}
}
MLA
Cite this
MLA Copy
Shpichka, Anastasia, et al. “Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19).” International Journal of Bioprinting, vol. 6, no. 4, Jan. 2020, pp. 1-20. https://doi.org/10.18063%2FIJB.V6I4.302.
Found error?